Use of a reverse-transcriptase inhibitor in the prevention and treatment of degenerative diseases
The invention relates to the use of a reverse-transcriptase inhibitor in the prevention or treatment of a degenerative disease.
1. A method of treating or preventing a degenerative disease in a subject in need thereof, the method comprising administering a therapeutically effective amount of a reverse transcriptase inhibitor to the subject, said degenerative disease being selected from the group consisting of Parkinson's disease, Alzheimer's disease, Huntington's disease, a degenerative disease affecting eyesight and a degenerative disease affecting hearing.
2. The method of claim 1 , wherein the reverse transcriptase inhibitor is a nucleoside inhibitor.
3. The method of claim 2 , wherein the degenerative disease is linked to aging or oxidative stress.
4. The method of claim 1 , wherein the degenerative disease affecting eyesight is glaucoma.
5. The method of claim 1 , wherein the degenerative disease is Parkinson's disease.
6. The method of claim 1 , wherein the degenerative disease is Alzheimer's disease.
7. The method of claim 1 , wherein the degenerative disease is Huntington's disease.
8. The method of claim 1 , wherein the degenerative disease is a degenerative disease affecting eyesight.
9. The method of claim 1 , wherein the degenerative disease is a degenerative disease affecting hearing.